A new study published in the British Journal of Dermatology has revealed that people with chronic pruritus are twice as likely to...

New research shows that the Janus kinase (JAK) inhibitor abrocitinib, approved in Canada for the treatment of moderate-to-severe atopic...

Tildrakizumab was shown to be efficacious in treating moderate-to-severe plaque psoriasis on the scalp.

Two new and highly contagious fungal infections that cause difficult-to-treat skin rashes are prompting experts to alert healthcare...

Charitable donations are still being accepted for the 8th annual Galderma Walk for Camp Liberté, held on June 6, 2024. Camp Liberté is an...

Topical treatment decreases itch and improves sleep patterns in patients with psoriasis and atopic dermatitis.

A systematic review published as a short form communication in JAAD International has found evidence that low-dose isotretinoin can be an...

Findings from a new study suggest that taking oral contraceptives could be linked to frontal fibrosing alopecia (FFA). The study,...